Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology
F
Biotech is Zen Rated F and is the 141st ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
DRMA
DERMATA THERAPEUTICS INC
NASDAQ
Biotechnology
$3.90M$0.61-13.31%-$11.46M-0.14x0.37
United States
GLTO
GALECTO INC
NASDAQ
Biotechnology
$4.39M$3.32-7.52%-$18.36M-0.21x0.12
United States
ADAP
ADAPTIMMUNE THERAPEUTICS PLC
NASDAQ
Biotechnology
$26.56M$0.10-4.76%-$50.18M-0.42x-5.22
United Kingdom
EXOZ
EXOZYMES INC
NASDAQ
Biotechnology
$84.51M$10.10-0.20%-$6.57M-10.52x0.30
United States
ATHA
ATHIRA PHARMA INC
NASDAQ
Biotechnology
$13.94M$0.36-7.99%-$78.53M-0.17x0.17
United States
CUE
CUE BIOPHARMA INC
NASDAQ
Biotechnology
$61.41M$0.82-0.61%-$37.52M-1.27x2.38
United States
BRNS
BARINTHUS BIOTHERAPEUTICS PLC
NASDAQ
Biotechnology
$58.09M$1.44-5.88%-$56.91M-0.88x0.23
United Kingdom
ENSC
ENSYSCE BIOSCIENCES INC
NASDAQ
Biotechnology
$4.93M$2.08-5.45%-$6.77M-0.32x0.62
United States
LSTA
LISATA THERAPEUTICS INC
NASDAQ
Biotechnology
$21.75M$2.53-1.56%-$20.10M-1.10x0.15
United States
EPIX
ESSA PHARMA INC
NASDAQ
Biotechnology
$83.45M$1.880.53%-$28.40M-2.98x0.02
Canada
COCP
COCRYSTAL PHARMA INC
NASDAQ
Biotechnology
$16.99M$1.67-3.97%-$16.07M-1.06x0.46
United States
CLSD
CLEARSIDE BIOMEDICAL INC
NASDAQ
Biotechnology
$34.97M$0.45-6.25%-$29.81M-1.10x-1.43
United States
ESLA
ESTRELLA IMMUNOPHARMA INC
NASDAQ
Biotechnology
$31.64M$0.88-6.91%-$10.48M-2.82x-2.34
United States
BOLT
BOLT BIOTHERAPEUTICS INC
NASDAQ
Biotechnology
$11.14M$5.81-5.22%-$59.49M-0.18x0.83
United States
EQ
EQUILLIUM INC
NASDAQ
Biotechnology
$13.75M$0.39-3.51%-$13.49M-0.96x0.58
United States
EDSA
EDESA BIOTECH INC
NASDAQ
Biotechnology
$15.94M$2.27-0.87%-$5.67M-1.43x0.06
Canada
CELU
CELULARITY INC
NASDAQ
Biotechnology
$77.83M$3.251.88%-$43.55M-1.23x14.01
United States
DARE
DARE BIOSCIENCE INC
NASDAQ
Biotechnology
$21.11M$2.39-3.83%-$1.49M-14.03x-2.95
United States
CMMB
CHEMOMAB THERAPEUTICS LTD
NASDAQ
Biotechnology
$20.37M$1.08-0.92%N/A-1.64x0.23
Israel
CYCN
CYCLERION THERAPEUTICS INC
NASDAQ
Biotechnology
$8.47M$2.64-3.30%-$3.01M-2.28x0.12
United States
CLLS
CELLECTIS SA
NASDAQ
Biotechnology
$193.01M$2.67-4.81%-$11.34M-3.99x2.13
France
CNTX
CONTEXT THERAPEUTICS INC
NASDAQ
Biotechnology
$72.57M$0.81-2.53%-$27.55M-2.61x0.02
United States
CASI
CASI PHARMACEUTICALS INC
NASDAQ
Biotechnology
$23.55M$1.520.00%N/A-0.60x-6.06
China
CANF
CAN-FITE BIOPHARMA LTD
NYSEMKT
Biotechnology
$6.09M$0.68-4.76%-$7.84MN/A0.68
Israel
CALC
CALCIMEDICA INC
NASDAQ
Biotechnology
$51.42M$3.68-2.65%-$18.37M-2.36x1.33
United States
INTS
INTENSITY THERAPEUTICS INC
NASDAQ
Biotechnology
$5.61M$0.31-4.98%-$14.99M-0.29x8.18
United States
BYSI
BEYONDSPRING INC
NASDAQ
Biotechnology
$81.84M$2.031.00%N/AN/A-1.76
United States
BRTX
BIORESTORATIVE THERAPIES INC
NASDAQ
Biotechnology
$11.11M$1.48-3.27%-$11.78M-1.01x0.68
United States
PTHS
PELTHOS THERAPEUTICS INC
NYSEMKT
Biotechnology
$14.37M$21.79-1.00%-$7.07M-1.76x-1.22
United States
XBIO
XENETIC BIOSCIENCES INC
NASDAQ
Biotechnology
$5.04M$3.27-7.89%-$3.67M-1.37x0.13
United States
VIVS
VIVOSIM LABS INC
NASDAQ
Biotechnology
$5.23M$2.011.01%-$1.78M-1.18x0.40
United States
BOLD
BOUNDLESS BIO INC
NASDAQ
Biotechnology
$26.64M$1.190.00%-$61.76M-0.42x0.40
United States
ENTO
ENTERO THERAPEUTICS INC
NASDAQ
Biotechnology
$2.17M$0.46-3.18%-$9.97M-0.06x-5.51
United States
BHST
BIOHARVEST SCIENCES INC
NASDAQ
Biotechnology
$128.38M$7.41-2.00%-$4.37M-14.82x-31.36
Canada
IVA
INVENTIVA SA
NASDAQ
Biotechnology
$308.03M$3.222.22%-$99.76M-0.94x-2.12
France
ICCC
IMMUCELL CORP
NASDAQ
Biotechnology
$58.38M$6.46-0.46%$2.43M-129.20x0.57
United States
GNPX
GENPREX INC
NASDAQ
Biotechnology
$6.54M$0.24-6.75%-$19.10M-0.08x0.55
United States
CARM
CARISMA THERAPEUTICS INC
NASDAQ
Biotechnology
$14.04M$0.34-0.88%-$44.47M-0.28x-1.44
United States
BCDA
BIOCARDIA INC
NASDAQ
Biotechnology
$11.34M$2.19-1.35%-$7.96M-0.94x-2.43
United States
CRGX
CARGO THERAPEUTICS INC
NASDAQ
Biotechnology
$206.13M$4.47-0.45%-$209.75M-0.97x0.28
United States
SLGL
SOL-GEL TECHNOLOGIES LTD
NASDAQ
Biotechnology
$34.77M$12.484.00%-$10.35M-3.28x0.24
Israel
CNTB
CONNECT BIOPHARMA HOLDINGS LTD
NASDAQ
Biotechnology
$116.68M$2.1020.00%N/AN/A0.12
United States
EVGN
EVOGENE LTD
NASDAQ
Biotechnology
$7.87M$1.18-5.60%-$9.15M-0.49x-6.01
Israel
ORMP
ORAMED PHARMACEUTICALS INC
NASDAQ
Biotechnology
$87.01M$2.13-3.18%-$35.72M-3.00x0.05
United States
LVTX
LAVA THERAPEUTICS NV
NASDAQ
Biotechnology
$37.35M$1.42-3.40%-$29.00M-1.20x1.76
Netherlands
ARTL
ARTELO BIOSCIENCES INC
NASDAQ
Biotechnology
$6.76M$12.370.81%-$9.68M-0.69x4.39
United States
ARMP
ARMATA PHARMACEUTICALS INC
NYSEMKT
Biotechnology
$86.86M$2.40-1.23%$13.48MN/A-2.62
United States
CMND
CLEARMIND MEDICINE INC
NASDAQ
Biotechnology
$5.08M$0.990.10%-$4.58M-0.90x1.25
Canada (Federal Level)
KTTA
PASITHEA THERAPEUTICS CORP
NASDAQ
Biotechnology
$5.44M$0.730.14%-$12.96M-0.07x0.13
United States
APRE
APREA THERAPEUTICS INC
NASDAQ
Biotechnology
$10.18M$1.844.55%-$15.27M-0.78x0.30
United States
AZTR
AZITRA INC
NYSEMKT
Biotechnology
$3.06M$0.19-1.59%-$8.63M-0.06x0.34
United States
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
NASDAQ
Biotechnology
$26.86M$2.35-3.50%-$13.37M-1.92x0.39
Israel
MOLN
MOLECULAR PARTNERS AG
NASDAQ
Biotechnology
$140.12M$3.80-3.77%-$68.31M-1.83x0.10
Switzerland
APM
APTORUM GROUP LTD
NASDAQ
Biotechnology
$9.31M$1.661.84%-$3.82M-2.13x0.21
China
APLT
APPLIED THERAPEUTICS INC
NASDAQ
Biotechnology
$60.88M$0.43-2.93%-$43.10M-1.54x0.55
United States
ANTX
AN2 THERAPEUTICS INC
NASDAQ
Biotechnology
$32.29M$1.07-0.93%-$45.35M-0.71x0.11
United States
CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC
NASDAQ
Biotechnology
$7.11M$2.754.96%-$5.98M-0.72x0.04
United States
BCAB
BIOATLA INC
NASDAQ
Biotechnology
$17.64M$0.364.31%-$61.01M-0.30x69.00
United States
MNOV
MEDICINOVA INC
NASDAQ
Biotechnology
$66.21M$1.351.50%-$10.96M-5.87x0.05
United States
AIM
AIM IMMUNOTECH INC
NYSEMKT
Biotechnology
$2.33M$3.05-3.17%-$13.89M-0.13x-2.62
United States
PPBT
PURPLE BIOTECH LTD
NASDAQ
Biotechnology
$107.56M$2.08-1.89%$4.61MN/A0.09
Israel
ADAG
ADAGENE INC
NASDAQ
Biotechnology
$94.69M$2.011.01%-$31.65M-2.73x0.77
China
ADIL
ADIAL PHARMACEUTICALS INC
NASDAQ
Biotechnology
$3.74M$0.47-21.78%-$8.95M-0.32x0.62
United States
SYBX
SYNLOGIC INC
NASDAQ
Biotechnology
$17.78M$1.52-1.30%$1.50M12.67x0.37
United States
XTLB
XTL BIOPHARMACEUTICALS LTD
NASDAQ
Biotechnology
$14.45M$1.64-3.53%-$1.16M-8.20x0.57
United States
SRZN
SURROZEN INC
NASDAQ
Biotechnology
$80.38M$9.391.48%-$78.74M-0.38x19.24
United States
TCRT
ALAUNOS THERAPEUTICS INC
NASDAQ
Biotechnology
$4.71M$2.873.61%-$4.07M-1.13x1.00
United States
SNGX
SOLIGENIX INC
NASDAQ
Biotechnology
$4.08M$1.25-1.57%-$9.98M-0.29x1.14
United States
SLRX
SALARIUS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.67M$0.78-21.70%-$5.57M-0.16x36.81
United States
TENX
TENAX THERAPEUTICS INC
NASDAQ
Biotechnology
$25.85M$6.230.16%-$24.20M-3.00x0.03
United States
ASBP
ASPIRE BIOPHARMA HOLDINGS INC
NASDAQ
Biotechnology
$21.20M$0.43-10.08%-$17.14M-2.68x-1.28
Puerto Rico
QNRX
QUOIN PHARMACEUTICALS LTD
NASDAQ
Biotechnology
$7.87M$7.65-2.11%-$10.35MN/A1.19
Israel
SER
SERINA THERAPEUTICS INC
NYSEMKT
Biotechnology
$54.32M$5.45-8.63%-$235.00k545.00x3.04
United States
OKYO
OKYO PHARMA LTD
NASDAQ
Biotechnology
$94.40M$2.51-0.99%-$7.09M-12.55x-1.66
United Kingdom
PALI
PALISADE BIO INC
NASDAQ
Biotechnology
$5.08M$1.06-2.75%-$13.01M-0.16x0.54
United States
SCNI
SCINAI IMMUNOTHERAPEUTICS LTD
NASDAQ
Biotechnology
$0.00$1.61-19.50%-$4.47MN/A0.35
Israel
SABS
SAB BIOTHERAPEUTICS INC
NASDAQ
Biotechnology
$21.00M$2.26-0.22%-$30.38M-0.61x0.78
United States
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
NASDAQ
Biotechnology
$21.69M$0.46-1.28%-$28.87M-0.59x-2.59
United States
PHAR
PHARMING GROUP NV
NASDAQ
Biotechnology
$686.43M$10.092.33%$10.50M-42.22x0.88
Netherlands
SAGE
SAGE THERAPEUTICS INC
NASDAQ
Biotechnology
$543.55M$8.68-0.23%-$353.59M-1.50x0.15
United States
RNTX
REIN THERAPEUTICS INC
NASDAQ
Biotechnology
$28.14M$1.271.60%-$62.81M-0.40x0.16
United States
TNFA
TNF PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.77M$0.13-18.83%-$14.68M-0.02x0.57
United States
RLYB
RALLYBIO CORP
NASDAQ
Biotechnology
$19.97M$0.482.13%-$48.06M-0.44x0.07
United States
RENB
RENOVARO INC
NASDAQ
Biotechnology
$48.02M$0.28-3.79%-$66.08M-0.87x0.33
United States
TOVX
THERIVA BIOLOGICS INC
NYSEMKT
Biotechnology
$3.52M$0.43-2.49%-$24.23M-0.03x1.08
United States
PHGE
BIOMX INC
NYSEMKT
Biotechnology
$10.68M$0.41-1.21%-$38.35M-0.16x0.86
United States
TSBX
TURNSTONE BIOLOGICS CORP
NASDAQ
Biotechnology
$8.12M$0.35-0.85%-$61.36M-0.13x0.38
United States
NBTX
NANOBIOTIX SA
NASDAQ
Biotechnology
$317.05M$6.69-3.79%-$65.47M-4.18x-2.03
France
AEON
AEON BIOPHARMA INC
NYSEMKT
Biotechnology
$8.31M$0.74-5.53%$169.21M0.00x-2.22
United States
PMN
PROMIS NEUROSCIENCES INC
NASDAQ
Biotechnology
$27.46M$0.840.00%-$933.94k-16.80x0.44
Canada
TTNP
TITAN PHARMACEUTICALS INC
NASDAQ
Biotechnology
$3.68M$4.020.00%-$4.21M-0.88x0.15
United States
QLGN
QUALIGEN THERAPEUTICS INC
NASDAQ
Biotechnology
$4.11M$2.52-0.20%-$6.02M-0.26x84.94
United States
PULM
PULMATRIX INC
NASDAQ
Biotechnology
$20.34M$5.575.69%-$12.03M-1.66x0.13
United States
PSTV
PLUS THERAPEUTICS INC
NASDAQ
Biotechnology
$15.05M$0.46-12.88%-$18.82M-0.18x-1.51
United States
PRTC
PURETECH HEALTH PLC
NASDAQ
Biotechnology
$447.72M$18.70-2.10%$53.07M8.90x0.47
United States
PMCB
PHARMACYTE BIOTECH INC
NASDAQ
Biotechnology
$7.04M$1.030.49%$20.25M1.39x0.09
United States
RADX
RADIOPHARM THERANOSTICS LTD
NASDAQ
Biotechnology
$30.25M$4.64-3.51%N/A-0.38x0.76
Australia
VANI
VIVANI MEDICAL INC
NASDAQ
Biotechnology
$84.72M$1.43-4.67%-$23.09M-3.33x2.05
United States
PASG
PASSAGE BIO INC
NASDAQ
Biotechnology
$19.11M$6.15-3.00%-$60.99M-0.30x0.84
United States
OSRH
OSR HOLDINGS INC
NASDAQ
Biotechnology
$16.67M$0.87-6.99%N/AN/A0.56
United States

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jul 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 49, which is 26 points higher than the biotech industry average of 23.

PBYI passed 16 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock lose -12.71% over the past year, overperforming other biotech stocks by 55 percentage points.

Puma Biotechnology has an average 1 year price target of $7.00, an upside of 121.52% from Puma Biotechnology's current stock price of $3.16.

Puma Biotechnology stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Ptc Therapeutics (NASDAQ:PTCT)


Ptc Therapeutics (NASDAQ:PTCT) is the #2 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ptc Therapeutics (NASDAQ:PTCT) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Ptc Therapeutics (NASDAQ:PTCT) has a Due Diligence Score of 35, which is 12 points higher than the biotech industry average of 23.

PTCT passed 11 out of 33 due diligence checks and has average fundamentals. Ptc Therapeutics has seen its stock return 54.22% over the past year, overperforming other biotech stocks by 122 percentage points.

Ptc Therapeutics has an average 1 year price target of $69.62, an upside of 36.66% from Ptc Therapeutics's current stock price of $50.94.

Ptc Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Ptc Therapeutics, 53.85% have issued a Strong Buy rating, 15.38% have issued a Buy, 23.08% have issued a hold, while 0% have issued a Sell rating, and 7.69% have issued a Strong Sell.

3. Rigel Pharmaceuticals (NASDAQ:RIGL)


Rigel Pharmaceuticals (NASDAQ:RIGL) is the #3 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Rigel Pharmaceuticals (NASDAQ:RIGL) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a Due Diligence Score of 35, which is 12 points higher than the biotech industry average of 23.

RIGL passed 11 out of 33 due diligence checks and has average fundamentals. Rigel Pharmaceuticals has seen its stock return 97.46% over the past year, overperforming other biotech stocks by 165 percentage points.

Rigel Pharmaceuticals has an average 1 year price target of $39.75, an upside of 89.2% from Rigel Pharmaceuticals's current stock price of $21.01.

Rigel Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Rigel Pharmaceuticals, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)


Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 7.26%, which is 5 percentage points higher than the biotech industry average of 1.87%.

Dominari Holdings's dividend payout ratio of -7.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)


Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 3.22%, which is 1 percentage points higher than the biotech industry average of 1.87%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.2% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.75%, which is the same as the biotech industry average of 1.87%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 34.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.35% in the last day, and down -2.52% over the last week. Vyne Therapeutics was the among the top losers in the biotechnology industry, dropping -72.36% yesterday.

VYNE Therapeutics shares are trading lower after the company announced its Phase 2b trial Repibresib Gel in nonsegmental vitiligo did not meet its primary endpoint.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -12.71% in the past year. It has overperformed other stocks in the biotech industry by 55 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 4.75% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

3. United Therapeutics (NASDAQ:UTHR)


United Therapeutics (NASDAQ:UTHR) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

United Therapeutics has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

United Therapeutics's stock has dropped -16.47% in the past year. It has overperformed other stocks in the biotech industry by 51 percentage points.

Are biotech stocks a good buy now?

53.23% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 101.38% over the next year.

2.11% of biotech stocks have a Zen Rating of A (Strong Buy), 4.23% of biotech stocks are rated B (Buy), 37.42% are rated C (Hold), 35.94% are rated D (Sell), and 20.3% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -199.97x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.